Trulicity 1,5 mg 0,5 ml Pen injectors 4 pcs
3250£
View analogsType 2 diabetes mellitus in adult patients to improve glycemic control:
As monotherapy (when diet and exercise fail to provide adequate glycemic control in patients for whom metformin is inappropriate due to intolerance or contraindications).
As combination therapy with other glucose-lowering medicinal products, including insulin, when these together with diet and exercise do not provide adequate glycemic control.
Form of Release: Syringe pen
Product Brand:
Eli Lilly
About the brand
Product Categories: Diabetes
Trulicity 1,5 mg 0,5 ml Pen injectors 4 pcs
Composition:
Active Substance: Dulaglutide 1.5 mg.
Excipients:
Sodium citrate dihydrate, anhydrous citric acid, mannitol, polysorbate 80 (vegetable-derived), water for injections.
Product Description:
Trulicity is an innovative long-acting hypoglycemic agent classified as a glucagon-like peptide-1 (GLP-1) receptor agonist.
It stimulates insulin secretion in response to elevated blood glucose levels, suppresses inappropriate glucagon secretion, and moderately slows gastric emptying, providing stable glycemic control throughout the week.
Indications for Use:
Type 2 diabetes mellitus in adult patients to improve glycemic control:
As monotherapy (when diet and exercise fail to provide adequate glycemic control in patients for whom metformin is inappropriate due to intolerance or contraindications).
As combination therapy with other glucose-lowering medicinal products, including insulin, when these together with diet and exercise do not provide adequate glycemic control.
Method of Administration and Dosage:
- Administer subcutaneously (SC) into the abdomen, thigh, or upper arm at any time of day, independently of meals.
Do not administer intravenously (IV) or intramuscularly (IM). - The recommended dose is 0.75 mg once weekly for monotherapy; the recommended dose is 1.5 mg once weekly for combination therapy.
For patients aged 75 years and older, the recommended starting dose is 0.75 mg once weekly. - Injection sites may be rotated each week.
The injection should be given once a week on the same day (it is recommended to mark the calendar). - Operating the Prefilled Pen:
- Remove the pen from the refrigerator, check the label and expiration date, and inspect the solution for clarity (it should be clear, colorless, and free of visible particles). Wash hands.
- Pull off the base cap and discard it (do not put the cap back on or touch the needle).
- Place the clear base flat against the skin at the injection site and unlock the ring.
- Press and hold the green injection button until you hear a loud click.
Continue holding the clear base firmly against the skin until you hear a second click, which indicates completion of the injection (when the gray part becomes visible, approximately 5–10 seconds).
Contraindications:
- Hypersensitivity to dulaglutide or to any of the excipients.
- Type 1 diabetes mellitus and diabetic ketoacidosis.
- Severe renal impairment.
- Heart failure.
- Severe gastrointestinal disease, including severe gastroparesis, and acute pancreatitis.
- Pregnancy and breastfeeding.
- Pediatric and adolescent patients under 18 years of age.
Warnings and Precautions:
Dulaglutide delays gastric emptying; therefore, use with caution in patients receiving concomitant oral medicinal products that require rapid gastrointestinal absorption.
The prefilled pen contains glass parts; handle with care. If dropped on a hard surface, do not use the pen—use a new one instead.
Patients with severe visual impairment should not use the Trulicity single-use pen without the assistance of a person trained in its use.
Adverse Reactions / Side Effects:
- Gastrointestinal Disorders: Very common — decreased appetite, dyspepsia, nausea, diarrhea, vomiting, abdominal pain, constipation, flatulence, abdominal distension, gastroesophageal reflux disease, eructation.
- Metabolism and Nutrition Disorders: Common — hypoglycemia (especially when combined with sulfonylureas or insulin).
- Cardiac and Investigations: Common — sinus tachycardia, first-degree atrioventricular (AV) block.
- General Disorders: Common — fatigue.
Pregnancy and Lactation:
Contraindicated during pregnancy and breastfeeding. Women of childbearing potential are advised to use reliable contraception during treatment.
Storage Conditions:
- Store in the refrigerator (2°C to 8°C) in the original carton to protect from light.
- Do not freeze!
- Do not use the pen if it has been frozen.
When refrigeration is not available, the pen may be stored at temperatures not exceeding 30°C for up to 14 days. - Keep out of reach of children.
Packaging:
Cardboard box containing a plastic tray with 4 single-use prefilled pens and a package leaflet.
Injection needles are integrated into the prefilled pens and do not need to be purchased separately.
For convenient transportation of the product, you can also add a thermal bag to your order.
Tags, Keywords:
Active Ingredients:
No comments yet. Be the first to write one.
Your comment will be published after moderation.
You’ll receive a notification to your email when someone replies.
Русский
English
عربي

